Brief: Biocon Says Biocon Pharma Receives Health Canada Approval For Micafungin For Injection, USP, 50 Mg And 100 Mg
11/05/2026 04:05
May 11 (Reuters) - Biocon Ltd BION.NS: BIOCON - BIOCON PHARMA RECEIVES HEALTH CANADA APPROVAL FOR MICAFUNGIN FOR INJECTION, USP, 50 MG AND 100 MG Source text: ID:nnAZN4SVCE2 Further company coverage: BION.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biocon
See all newsBrief: Biocon Says Biocon Pharma Receives Health Canada Approval For Micafungin For Injection, USP, 50 Mg And 100 Mg
India's Biocon gains after Q4 results
Biocon's Mazumdar-Shaw sets out 5-year succession plan, names niece Claire as successor (updated)
Biocon chair Kiran Mazumdar-Shaw identifies successor as Indian pharma firm plans transition
Brief: Biocon Chair Kiran Mazumdar-Shaw Says Want Niece Claire Mazumdar To Succeed In A Well-Phased Manner Over A Five-Year Period